ProfileGDS5678 / 1434632_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 48% 51% 51% 51% 51% 51% 51% 65% 51% 52% 51% 58% 53% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1834248
GSM967853U87-EV human glioblastoma xenograft - Control 23.2380251
GSM967854U87-EV human glioblastoma xenograft - Control 33.2310351
GSM967855U87-EV human glioblastoma xenograft - Control 43.1748151
GSM967856U87-EV human glioblastoma xenograft - Control 53.1748651
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3409551
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3003951
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.8831965
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2189151
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2340652
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2272451
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.466158
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3081553
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2432852